Thursday, December 23, 2021 10:57:07 PM
Diver, I agree with you completely, but frankly can't understand why. I know that many Institutions aren't supposed to invest in OTC's, or stocks under $5, but by the same token, I know they can by purchasing and selling within the same quarter. I don't know how much of this is happening.
I know many individual investors who invest in much the same way, they aren't interested in stocks under $1, or $5, but give them news that the stocks moved from $.70 to $5 and they're in with both feet. The beauty is that people like us can purchase multiple times the shares for the same money, the key however is not for us to sell it to them when it's at their threshold. If most of us small investors don't sell, instead of $5 they'll either be paying $10 or more, or the MM's and Institutions will convince the company to meet their demands with an offering which provides funds for the company.
Imagine what happens if none of us sell, even a single share, below $10, I don't think it will take much time to reach $10, how about not below $20. It won't happen, some here may profit nicely and sell at $2, but it would really be nice if we held on for $20.
Happy Holidays,
Gary
I know many individual investors who invest in much the same way, they aren't interested in stocks under $1, or $5, but give them news that the stocks moved from $.70 to $5 and they're in with both feet. The beauty is that people like us can purchase multiple times the shares for the same money, the key however is not for us to sell it to them when it's at their threshold. If most of us small investors don't sell, instead of $5 they'll either be paying $10 or more, or the MM's and Institutions will convince the company to meet their demands with an offering which provides funds for the company.
Imagine what happens if none of us sell, even a single share, below $10, I don't think it will take much time to reach $10, how about not below $20. It won't happen, some here may profit nicely and sell at $2, but it would really be nice if we held on for $20.
Happy Holidays,
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
